Octapharma
Horizon Surpasses Roche in Rare Disease Reputation, While Pfizer’s Standing Declines
Anika Sharma
Horizon Therapeutics continues to collect accolades as it progresses toward its acquisition, with rare disease organizations now recognizing its excellence. ...
Balfaxar, a warfarin reversal medication from Octapharma, receives FDA approval
SG Tylor
Source – Octapharma More than 2.4 million individuals in the United States rely on warfarin, a blood thinner, to prevent ...
